|
R
|
Quarterly
Report Pursuant To Section 13 Or 15(d) Of The Securities Exchange
Act Of
1934
|
¨
|
Transition
Report Pursuant To Section 13 Or 15(d) Of The Securities Exchange
Act Of
1934
|
|
|
|
Nevada
|
|
88-0200415
|
(State
or Other Jurisdiction
of
Incorporation or Organization)
|
|
(I.R.S.
Employer Identification No.)
|
|
|
|
2724
North Tenaya Way, Las Vegas, NV
|
|
89128
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
Large
accelerated filer R
|
Accelerated
filer o
|
Non-accelerated
filer o
|
Part
I.
Financial Information
|
Page
No.
|
Item
1. Financial
Statements (Unaudited):
|
|
1
|
|
2
|
|
3
|
|
4
|
|
5-14
|
|
15-26
|
|
27
|
|
27
|
|
|
|
Part
II. Other Information
|
|
28-29
|
|
29
|
|
30
|
|
30
|
|
30
|
|
30
|
|
31
|
|
32
|
March
31, 2007
|
December
31, 2006
|
||||||
Assets
|
|||||||
Current
assets:
|
|||||||
Cash
and cash equivalents
|
$
|
77,242
|
$
|
58,918
|
|||
Investments
|
345,460
|
323,846
|
|||||
Accounts
receivable (less allowance for doubtful accounts:
|
|||||||
2007
- $6,728; 2006 - $5,518)
|
24,881
|
21,308
|
|||||
Current
portion of deferred tax asset
|
47,955
|
29,861
|
|||||
Prepaid
expenses and other current assets
|
126,757
|
110,020
|
|||||
Total
current assets
|
622,295
|
543,953
|
|||||
Property
and equipment, net
|
70,269
|
71,893
|
|||||
Restricted
cash and investments
|
19,470
|
19,428
|
|||||
Goodwill
|
14,782
|
14,782
|
|||||
Deferred
tax asset (less current portion)
|
25,983
|
18,656
|
|||||
Note
receivable (less valuation allowance: 2007 and 2006 -
$15,000)
|
47,000
|
47,000
|
|||||
Other
assets
|
90,349
|
93,700
|
|||||
Total
assets
|
$
|
890,148
|
$
|
809,412
|
|||
Liabilities
and stockholders'
equity
|
|||||||
Current
liabilities:
|
|||||||
Accrued
and other current liabilities
|
$
|
97,801
|
$
|
99,314
|
|||
Trade
accounts payable
|
1,902
|
1,552
|
|||||
Accrued
payroll and taxes
|
23,906
|
25,925
|
|||||
Medical
claims payable
|
219,170
|
222,895
|
|||||
Premium
deficiency reserve
|
45,309
|
1,076
|
|||||
Unearned
premium revenue
|
121,958
|
52,075
|
|||||
Current
portion of long-term debt
|
132
|
116
|
|||||
Total
current liabilities
|
510,178
|
402,953
|
|||||
Long-term
debt (less current portion)
|
70,523
|
118,734
|
|||||
Other
liabilities
|
90,712
|
71,007
|
|||||
Total
liabilities
|
671,413
|
592,694
|
|||||
Commitments
and contingencies
|
|||||||
Stockholders'
equity:
|
|||||||
Preferred
stock, $.01 par value, 1,000 shares authorized;
|
|||||||
none
issued or outstanding
|
|||||||
Common
stock, $.005 par value, 120,000 shares authorized; 2007 - 73,525;
|
¾
|
¾
|
|||||
2006
- 70,835 shares issued; 2007
- 55,948; 2006 - 53,824 shares outstanding
|
368
|
354
|
|||||
Treasury
stock at cost: 2007 - 17,577; 2006 - 17,011 common stock
shares
|
(620,951
|
)
|
(600,539
|
)
|
|||
Additional
paid-in capital
|
464,804
|
436,643
|
|||||
Accumulated
other comprehensive loss
|
(8,559
|
)
|
(8,635
|
)
|
|||
Retained
earnings
|
383,073
|
388,895
|
|||||
Total
stockholders' equity
|
218,735
|
216,718
|
|||||
Total
liabilities and stockholders' equity
|
$
|
890,148
|
$
|
809,412
|
Three
Months Ended March 31,
|
|||||||
2007
|
2006
|
||||||
Operating
revenues:
|
|||||||
Medical
premiums
|
$
|
468,074
|
$
|
414,444
|
|||
Professional
fees
|
14,642
|
12,915
|
|||||
Investment
and other revenues
|
11,921
|
10,889
|
|||||
Total
|
494,637
|
438,248
|
|||||
Operating
expenses:
|
|||||||
Medical
expenses
|
435,311
|
336,519
|
|||||
General
and administrative expenses
|
59,192
|
51,339
|
|||||
Total
|
494,503
|
387,858
|
|||||
Operating
income
|
134
|
50,390
|
|||||
Interest
expense
|
(1,955
|
)
|
(776
|
)
|
|||
Other
income (expense), net
|
650
|
(33
|
)
|
||||
(Loss)
income before income taxes
|
(1,171
|
)
|
49,581
|
||||
Provision
for income taxes
|
(68
|
)
|
(16,910
|
)
|
|||
Net
(loss) income
|
$
|
(1,239
|
)
|
$
|
32,671
|
||
Net
(loss) income per common share
|
$
|
(0.02
|
)
|
$
|
0.57
|
||
Net
(loss) income per common share assuming dilution
|
$
|
(0.02
|
)
|
$
|
0.51
|
Common
Stock
|
In
Treasury
|
Additional
Paid-in
|
Accumulated
Other
Comprehensive
|
Retained
|
Total
Stock-
holders'
|
||||||||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
Capital
|
Loss
|
Earnings
|
Equity
|
||||||||||||||||||
Balance,
January 1, 2006
|
69,136
|
$
|
346
|
11,006
|
$
|
(377,190
|
)
|
$
|
400,287
|
$
|
(1,750
|
)
|
$
|
262,559
|
$
|
284,252
|
|||||||||
Common
stock issued in connection with stock plans
|
384
|
2
|
(205
|
)
|
6,814
|
5,657
|
¾
|
(4,665
|
)
|
7,808
|
|||||||||||||||
Share-based
compensation expense
|
¾
|
¾
|
¾
|
¾
|
1,652
|
¾
|
8
|
1,660
|
|||||||||||||||||
Common
stock issued in connection with conversion of debentures
|
54
|
¾
|
¾
|
¾
|
500
|
¾
|
¾
|
500
|
|||||||||||||||||
Excess
tax benefits from share-based payment arrangements
|
¾
|
¾
|
¾
|
¾
|
5,109
|
¾
|
¾
|
5,109
|
|||||||||||||||||
Repurchase
of common stock shares
|
¾
|
¾
|
2,213
|
(91,131
|
)
|
¾
|
¾
|
¾
|
(91,131
|
)
|
|||||||||||||||
Comprehensive
income:
|
|||||||||||||||||||||||||
Net
income
|
¾
|
¾
|
¾
|
¾
|
¾
|
¾
|
32,671
|
32,671
|
|||||||||||||||||
Other
comprehensive income:
|
|||||||||||||||||||||||||
Net
unrealized holding loss on
available-for-sale
investments ($1,612 pretax)
|
¾
|
¾
|
¾
|
¾
|
¾
|
(1,048
|
)
|
¾
|
(1,048
|
)
|
|||||||||||||||
Total
comprehensive income
|
¾
|
¾
|
¾
|
¾
|
¾
|
(1,048
|
)
|
32,671
|
31,623
|
||||||||||||||||
Balance,
March 31, 2006
|
69,754
|
$
|
348
|
13,014
|
$
|
(461,507
|
)
|
$
|
413,205
|
$
|
(2,798
|
)
|
$
|
290,573
|
$
|
239,821
|
|||||||||
Balance,
January 1, 2007
|
70,835
|
$
|
354
|
17,011
|
$
|
(600,539
|
)
|
$
|
436,643
|
$
|
(8,635
|
)
|
$
|
388,895
|
$
|
216,718
|
|||||||||
Common
stock issued in connection with stock plans
|
147
|
1
|
(19
|
)
|
669
|
2,125
|
¾
|
(321
|
)
|
2,474
|
|||||||||||||||
Share-based
compensation expense
|
¾
|
¾
|
¾
|
¾
|
1,738
|
¾
|
6
|
1,744
|
|||||||||||||||||
Common
stock issued in connection with conversion of debentures
|
2,543
|
13
|
¾
|
¾
|
23,243
|
¾
|
¾
|
23,256
|
|||||||||||||||||
Excess
tax benefits from share-based payment arrangements
|
¾
|
¾
|
¾
|
¾
|
1,055
|
¾
|
¾
|
1,055
|
|||||||||||||||||
Repurchase
of common stock shares
|
¾
|
¾
|
585
|
(21,081
|
)
|
¾
|
¾
|
¾
|
(21,081
|
)
|
|||||||||||||||
Cumulative
effect from adoption of
FIN
48
|
¾
|
¾
|
¾
|
¾
|
¾
|
¾
|
(4,268
|
)
|
(4,268
|
)
|
|||||||||||||||
Comprehensive
income:
|
|||||||||||||||||||||||||
Net
loss
|
¾
|
¾
|
¾
|
¾
|
¾
|
¾
|
(1,239
|
)
|
(1,239
|
)
|
|||||||||||||||
Other
comprehensive income:
|
|||||||||||||||||||||||||
Net
unrealized holding loss on available-for-sale investments ($237
pretax)
|
¾
|
¾
|
¾
|
¾
|
¾
|
(154
|
)
|
(154
|
)
|
||||||||||||||||
Unfunded
portion of defined benefit pension plan ($354 pretax)
|
¾
|
¾
|
¾
|
¾
|
¾
|
230
|
230
|
||||||||||||||||||
Total
comprehensive loss
|
¾
|
¾
|
¾
|
¾
|
¾
|
76
|
(1,239
|
)
|
(1,163
|
)
|
|||||||||||||||
Balance,
March 31, 2007
|
73,525
|
$
|
368
|
17,577
|
$
|
(620,951
|
)
|
$
|
464,804
|
$
|
(8,559
|
)
|
$
|
383,073
|
$
|
218,735
|
|
Three
Months Ended March 31,
|
||||||
2007
|
2006
|
||||||
Cash
flows from operating activities:
|
|||||||
Net
(loss) income
|
$
|
(1,239
|
)
|
$
|
32,671
|
||
Adjustments
to reconcile net (loss) income to net cash
|
|||||||
provided
by operating activities:
|
|||||||
Depreciation
|
3,954
|
4,318
|
|||||
Share-based
compensation expense
|
1,744
|
1,660
|
|||||
Excess
tax benefits from share-based payment arrangements
|
(1,055
|
)
|
(5,109
|
)
|
|||
Provision
for doubtful accounts
|
1,108
|
538
|
|||||
Loss
on property and equipment dispositions
|
3
|
108
|
|||||
Change
in operating assets and liabilities:
|
|||||||
Deferred
tax asset
|
(24,283
|
)
|
2,628
|
||||
Other
current assets
|
(21,210
|
)
|
(23,107
|
)
|
|||
Other
assets
|
(2,449
|
)
|
(5,404
|
)
|
|||
Accrued
payroll and taxes
|
(2,019
|
)
|
(2,139
|
)
|
|||
Medical
claims payable
|
(3,725
|
)
|
26,434
|
||||
Other
current liabilities
|
4,566
|
35,670
|
|||||
Unearned
premium revenue
|
69,883
|
61,154
|
|||||
Premium
deficiency reserve
|
44,233
|
¾
|
|||||
Other
liabilities
|
15,666
|
127
|
|||||
Net
cash provided by operating activities
|
85,177
|
129,549
|
|||||
Cash
flows from investing activities:
|
|||||||
Capital
expenditures, net of dispositions
|
(2,233
|
)
|
(2,785
|
)
|
|||
Purchase
of investments, net of proceeds
|
(22,029
|
)
|
(57,630
|
)
|
|||
Net
cash used for investing activities
|
(24,262
|
)
|
(60,415
|
)
|
|||
Cash
flows from financing activities:
|
|||||||
Payments
on debt and capital leases
|
(25,039
|
)
|
(25
|
)
|
|||
Proceeds
from other long-term debt
|
¾
|
20,000
|
|||||
Purchase
of treasury stock
|
(21,081
|
)
|
(91,131
|
)
|
|||
Excess
tax benefits from share-based payment arrangements
|
1,055
|
5,109
|
|||||
Proceeds
from exercise of stock in connection with stock plans
|
2,474
|
7,808
|
|||||
Net
cash used for financing activities
|
(42,591
|
)
|
(58,239
|
)
|
|||
Net
increase in cash and cash equivalents
|
18,324
|
10,895
|
|||||
Cash
and cash equivalents at beginning of period
|
58,918
|
88,059
|
|||||
Cash
and cash equivalents at end of period
|
$
|
77,242
|
$
|
98,954
|
|||
Supplemental
condensed consolidated statement of cash flows
information:
|
|||||||
Cash
paid during the period for interest
|
$
|
2,158
|
$
|
1,141
|
|||
Net
cash paid during the period for income taxes
|
12,500
|
3
|
|||||
Non-cash
investing and financing activities:
|
|||||||
Senior
convertible debentures converted into Sierra common stock
|
23,256
|
500
|
|||||
Additions
to capital leases
|
100
|
¾
|
|||||
Investments
purchased but not settled
|
4,170
|
2,221
|
Three
Months Ended March 31,
|
|||||||
2007
|
2006
|
||||||
(In
thousands)
|
|||||||
Medical
expenses
|
$
|
190
|
$
|
187
|
|||
General
and administrative expenses
|
1,554
|
1,473
|
|||||
Share-based
compensation expense before income taxes
|
1,744
|
1,660
|
|||||
Income
tax benefit
|
(610
|
)
|
(581
|
)
|
|||
Net
share-based compensation expense
|
$
|
1,134
|
$
|
1,079
|
Weighted
|
|||||||||||||
Number
|
Weighted
|
Average
|
Aggregate
|
||||||||||
Of
|
Average
|
Contractual
Life
|
Intrinsic
|
||||||||||
Shares
|
Exercise
Price
|
Remaining
|
Value
|
||||||||||
(In
thousands)
|
(per
share)
|
(In
years)
|
(In
thousands)
|
||||||||||
Outstanding,
January 1, 2007
|
1,775
|
$
|
12.94
|
||||||||||
Granted
|
¾
|
¾
|
|||||||||||
Exercised
|
(113
|
)
|
8.64
|
||||||||||
Canceled
|
(10
|
)
|
18.08
|
||||||||||
Outstanding,
March 31, 2007
|
1,652
|
$
|
13.20
|
5.35
|
$
|
46,215
|
|||||||
Exercisable
at March 31, 2007
|
834
|
$
|
11.40
|
5.03
|
$
|
24,823
|
Number
|
Weighted-Average
|
||||||
Of
|
Grant
Date
|
||||||
Shares
|
Fair
Value
|
||||||
(In
thousands)
|
(per
share)
|
||||||
Nonvested
shares, January 1, 2007 (1)
|
803
|
$
|
7.34
|
||||
Granted
|
¾
|
¾
|
|||||
Vested
|
(140
|
)
|
7.55
|
||||
Canceled
|
(6
|
)
|
6.98
|
||||
Nonvested
shares, March 31, 2007 (1)
|
657
|
$
|
7.30
|
(1)
|
Excludes
164,000 and 161,000 shares at January 1, 2007 and March 31, 2007,
respectively, which vested in 2005, but are not exercisable until
2008.
|
Number
|
Aggregate
|
||||||
Of
|
Intrinsic
|
||||||
Shares
|
Value
|
||||||
(In
thousands)
|
|||||||
Outstanding,
January 1, 2007(1)(2)
|
104
|
||||||
Granted
|
10
|
||||||
Vested
|
¾
|
||||||
Canceled
|
¾
|
||||||
Outstanding,
March 31, 2007(1)(3)
|
114
|
$
|
4,693
|
Three
Months Ended March 31,
|
|||||||
2007
|
2006
|
||||||
Components
of net periodic benefit cost:
|
(In
thousands)
|
||||||
Service
cost
|
$
|
139
|
$
|
126
|
|||
Interest
cost
|
426
|
399
|
|||||
Amortization
of prior service credits
|
303
|
303
|
|||||
Recognized
actuarial loss
|
52
|
32
|
|||||
Net
periodic benefit cost
|
$
|
920
|
$
|
860
|
Three
Months Ended March 31,
|
|||||||
2007
|
2006
|
||||||
(In
thousands, except per share data)
|
|||||||
Basic
(loss) income per share:
|
|||||||
Net
(loss) income
|
$
|
(1,239
|
)
|
$
|
32,671
|
||
Weighted
average common shares outstanding
|
55,414
|
57,727
|
|||||
Net
(loss) income per common share
|
$
|
(0.02
|
)
|
$
|
0.57
|
||
Diluted
(loss) income per share:
|
|||||||
Net
(loss) income
|
$
|
(1,239
|
)
|
$
|
32,671
|
||
Interest
expense on Sierra debentures, net of tax
|
¾
|
189
|
|||||
(Loss)
income for purposes of computing diluted net (loss) income per
share
|
$
|
(1,239
|
)
|
$
|
32,860
|
||
Weighted
average common shares outstanding
|
55,414
|
57,727
|
|||||
Dilutive
options and restricted shares outstanding
|
¾
|
1,352
|
|||||
Dilutive
impact of conversion of Sierra debentures
|
¾
|
5,648
|
|||||
Weighted
average common shares outstanding assuming dilution
|
55,414
|
64,727
|
|||||
Net
(loss) income per common share assuming dilution
|
$
|
(0.02
|
)
|
$
|
0.51
|
10.
|
Recently
Issued Accounting
Standards
|
Three
Months Ended
March
31,
|
Percent
Of Revenue
Three
Months Ended
March
31,
|
Increase
(Decrease)
|
||||||||||||||||||||||||||
2007
|
2006
|
2007
|
2006
|
2007 vs. 2006 | ||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Operating
revenues:
|
(In
thousands, except percentages, per share and
membership)
|
|||||||||||||||||||||||||||
Medical
premiums
|
$
|
468,074
|
$
|
414,444
|
94.6
|
%
|
94.6
|
%
|
$
|
53,630
|
12.9
|
%
|
||||||||||||||||
Professional
fees
|
14,642
|
12,915
|
3.0
|
2.9
|
1,727
|
13.4
|
||||||||||||||||||||||
Investment
and other revenues
|
11,921
|
10,889
|
2.4
|
2.5
|
1,032
|
9.5
|
||||||||||||||||||||||
Total
|
494,637
|
438,248
|
100.0
|
100.0
|
56,389
|
12.9
|
||||||||||||||||||||||
Operating
expenses:
|
||||||||||||||||||||||||||||
Medical
expenses
|
435,311
|
336,519
|
88.0
|
76.8
|
98,792
|
29.4
|
||||||||||||||||||||||
Medical
care ratio
|
90.2
|
%
|
78.7
|
%
|
||||||||||||||||||||||||
General
and administrative expenses
|
59,192
|
51,339
|
12.0
|
11.7
|
7,853
|
15.3
|
||||||||||||||||||||||
Total
|
494,503
|
387,858
|
100.0
|
88.5
|
106,645
|
27.5
|
||||||||||||||||||||||
Operating
income
|
134
|
50,390
|
(0.0
|
)
|
11.5
|
(50,256
|
)
|
(99.7
|
)
|
|||||||||||||||||||
Interest
expense
|
(1,955
|
)
|
(776
|
)
|
(0.4
|
)
|
(0.2
|
)
|
(1,179
|
)
|
151.9
|
|||||||||||||||||
Other
income (expense), net
|
650
|
(33
|
)
|
0.1
|
¾
|
683
|
(2,069.7
|
)
|
||||||||||||||||||||
(Loss)
income before income taxes
|
(1,171
|
)
|
49,581
|
(0.3
|
)
|
11.3
|
(50,752
|
)
|
(102.4
|
)
|
||||||||||||||||||
Provision
for income taxes
|
(68
|
)
|
(16,910
|
)
|
0.0
|
(3.8
|
)
|
16,842
|
(99.6
|
)
|
||||||||||||||||||
Tax
rate
|
5.8
|
%
|
34.1
|
%
|
||||||||||||||||||||||||
Net
(loss) income
|
$
|
(1,239
|
)
|
$
|
32,671
|
(0.3
|
)%
|
7.5
|
%
|
$
|
(33,910
|
)
|
(103.8
|
)%
|
||||||||||||||
Net
(loss) income per common share assuming dilution
|
$
|
(0.02
|
)
|
$
|
0.51
|
$
|
(0.53
|
)
|
(103.9
|
)%
|
||||||||||||||||||
Membership
|
||||||||||||||||||||||||||||
HMO:
|
||||||||||||||||||||||||||||
Commercial
|
275,300
|
260,800
|
14,500
|
5.6
|
%
|
|||||||||||||||||||||||
Medicare
|
56,800
|
56,400
|
400
|
0.7
|
||||||||||||||||||||||||
Medicaid
|
59,600
|
55,000
|
4,600
|
8.4
|
||||||||||||||||||||||||
Subtotal
HMO
|
391,700
|
372,200
|
19,500
|
5.2
|
||||||||||||||||||||||||
Commercial
PPO and HSA
|
34,300
|
28,600
|
5,700
|
19.9
|
||||||||||||||||||||||||
Medicare
PPO and PFFS
|
2,900
|
900
|
2,000
|
222.2
|
||||||||||||||||||||||||
Medicare
Part D-Basic
|
159,100
|
160,800
|
(1,700
|
)
|
(1.1
|
)
|
||||||||||||||||||||||
Medicare
Part D-Enhanced
|
43,200
|
¾
|
43,200
|
¾
|
||||||||||||||||||||||||
Medicare
supplement
|
13,100
|
14,600
|
(1,500
|
)
|
(10.3
|
)
|
||||||||||||||||||||||
Administrative
services
|
218,200
|
214,600
|
3,600
|
1.7
|
||||||||||||||||||||||||
Total
membership
|
862,500
|
791,700
|
70,800
|
8.9
|
%
|
|||||||||||||||||||||||
Member
months
|
||||||||||||||||||||||||||||
HMO:
|
||||||||||||||||||||||||||||
Commercial
|
823,300
|
777,600
|
45,700
|
5.9
|
%
|
|||||||||||||||||||||||
Medicare
|
170,500
|
168,900
|
1,600
|
1.0
|
||||||||||||||||||||||||
Medicaid
|
180,200
|
166,900
|
13,300
|
8.0
|
·
|
Total
operating revenues increased by 12.9%. This improvement was primarily
driven by a 12.9% increase in medical premiums due to a 37.6% increase
in
our stand alone Medicare Part D prescription drug (PDP) programs,
an
increase in our HMO membership and premium rate increases. Also
contributing to the improvement in operating revenues was a 13.4%
increase
in professional fees due to an increase in visits to our clinical
subsidiaries and a 9.5% increase in investment and other revenues
due to
an increase in yield during 2007 and higher average invested
balances.
|
·
|
HMO
membership increased 5.2% as a result of new accounts and in-case
growth
on commercial membership and continued growth in Medicaid membership.
This
increase includes the 11,000 commercial member terminations effective
January 1, 2007, from three large employer groups that had been
anticipated.
|
·
|
Medical
expenses, as a percentage of medical premiums and professional fees,
or
medical care ratio, increased to 90.2% in 2007 from 78.7% in 2006.
The
increase in our medical care ratio is primarily related to
the
|
·
|
General
and administrative (G&A) expenses as a percentage of medical premiums
increased to 12.6% in 2007 from 12.4% in 2006. G&A expenses increased
15.3% primarily due to expenses related to our new enhanced PDP product,
costs associated with our pending merger with UnitedHealth Group,
and
increases in premium taxes and brokers' fees.
|
·
|
We
had operating income of $134,000 in 2007 compared to $50.4 million
in
2006. This decrease in income is related to the $48.8 million operating
loss recorded during 2007 related to our new enhanced PDP product. See
Medical Expenses below for more
details.
|
·
|
Cash
flows from operating activities decreased to $85.2 million from
$129.5
million during 2006. This decrease is mostly due to a $50.0 million
decrease in operating cash flows from our PDP plans during 2007
compared
to 2006, primarily as a result of the timing of claim payments
during the
quarter.
|
Three
Months Ended March 31,
|
|||||||
2007
|
2006
|
||||||
(In
thousands)
|
|||||||
Sources
of cash:
|
|||||||
Cash
provided by operating activities
|
$
|
85,177
|
$
|
129,549
|
|||
Exercise
of stock in connection with stock plans
|
2,474
|
7,808
|
|||||
Proceeds
from other long-term debt
|
¾
|
20,000
|
|||||
Other
|
1,055
|
5,109
|
|||||
Total
cash sources
|
88,706
|
162,466
|
|||||
Uses
of cash:
|
|||||||
Purchase
of investments, net of proceeds
|
(22,029
|
)
|
(57,630
|
)
|
|||
Purchase
of treasury stock
|
(21,081
|
)
|
(91,131
|
)
|
|||
Payment
on debt
|
(25,039
|
)
|
(25
|
)
|
|||
Other
|
(2,233
|
)
|
(2,785
|
)
|
|||
Total
cash uses
|
(70,382
|
)
|
(151,571
|
)
|
|||
Net
increase
in cash
|
$
|
18,324
|
$
|
10,895
|
A.M.
Best Company, Inc. (1)
|
Fitch
Ratings (2)
|
||||||||||||
Rating
|
Ranking
|
Rating
|
Ranking
|
||||||||||
Financial
strength rating:
|
|||||||||||||
HMO
and health and life insurance subsidiaries
|
B++
Very Good
|
5th
of 16
|
A-
Strong
|
7th
of 23
|
|||||||||
Issuer
credit ratings:
|
|||||||||||||
HMO
and health and life insurance subsidiaries
|
bbb+
Very Good
|
8th
of 22
|
n/a
|
n/a
|
|||||||||
Parent
company
|
bb+
Speculative
|
11th
of 22
|
BBB
Good
|
9th
of 23
|
|||||||||
Senior
convertible debentures
|
bb+
Speculative
|
11th
of 22
|
BBB-
Investment Grade
|
10th
of 23
|
Standard
& Poor's Corp. (3)
|
||||||
Rating
|
Ranking
|
|||||
Counterparty
credit rating
|
BB+
Speculative
|
11th
of 22
|
||||
Senior
convertible debentures
|
BB+
Speculative
|
11th
of 22
|
•
|
|
current
and prospective employees may experience uncertainty about their
future
roles with the combined company, which might adversely affect our
ability
to retain key managers and other employees;
|
•
|
|
the
merger agreement with UnitedHealth Group imposes certain restrictions
on
the operations of our business until completion of the merger; and
|
•
|
|
current
or prospective customers may experience uncertainty about potential
merger
transition complexities.
|
(c)
|
Below,
is a summary of stock repurchases for the three months ended March
31,
2007. See Note 7, "Share Repurchases", of our Notes to Condensed
Consolidated Financial Statements for information regarding our stock
repurchase plan.
|
Period
|
Total
Number
Of
Shares
Repurchased
(1)
|
Average
Price
Paid
Per
Share
|
Total
Number
Of
Shares Purchased
As
Part Of Publicly
Announced
Plan
Or
Program
|
Approximate
Dollar
Value
Of Shares
That
May Yet Be
Purchased
Under
The
Plan (2)
|
|||||||||
(In
thousands, except per share data)
|
|||||||||||||
Beginning
approximate dollar value of shares that may yet be
purchased
|
$
|
24,142
|
|||||||||||
January
1, 2007 - January 31, 2007
|
500
|
$
|
35.80
|
500
|
56,251
|
||||||||
February
1, 2007 - February 28, 2007
|
85
|
37.45
|
85
|
53,070
|
|||||||||
March
1, 2007 - March 31, 2007
|
¾
|
¾
|
¾
|
53,070
|
(1)
|
Repurchases
were made pursuant to a 10b5-1
plan.
|
(2)
|
At
January 1, 2007, $24.1 million remained available for purchase under
previously approved plans. On January 25, 2007, our Board of Directors
authorized an additional $50.0 million in share repurchases. The
repurchase program has no stated expiration date; however we have
halted
our repurchase program pending the UnitedHealth Group merger.
|
(d)
|
Below,
is a summary of 2¼% senior convertible debenture conversions for the three
months ended March 31, 2007. See Note 5, "Long-Term Debt", of our
Notes to
Condensed Consolidated Financial Statements for information regarding
our
senior convertible debentures.
|
Period
|
Total
Dollar Value of Debentures Converted
|
AveragePrice
Paid
Per Debenture
|
Total
Dollar Value
Of
Debentures
Purchased
As
Part Of Publicly
Announced
Plan
Or
Program
|
Approximate
Dollar
Value
Of Debentures
That
May Yet Be
Purchased
UnderThe
Plan
|
|||||||||
January
1, 2007 - January 31, 2007
|
$
|
21,720,000
|
109.35
shares of common stock for each $1,000 principal amount of
debentures
|
none
|
none
|
||||||||
February
1, 2007 - February 28, 2007
|
¾
|
¾
|
¾
|
¾
|
|||||||||
March
1, 2007 - March 31, 2007
|
1,536,000
|
109.35
shares of common stock for each $1,000 principal amount of
debentures
|
none
|
none
|
(31.1)
|
Rule
13a - 14(a) or 15d - 14(a) Certification of Chief Executive Officer.
|
(31.2)
|
Rule
13a - 14(a) or 15d - 14(a) Certification of Chief Financial Officer.
|
(32.1)
|
Certification
pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section
906 of
the Sarbanes-Oxley Act of 2002 of Principal Executive Officer.
|
(32.2)
|
Certification
pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section
906 of
the Sarbanes-Oxley Act of 2002 of Principal Financial Officer.
|
|
SIERRA
HEALTH SERVICES, INC.
Registrant
By:
/s/ MARC R. BRIGGS
Marc
R. Briggs
Senior
Vice President of Finance,
Chief
Financial Officer and Treasurer
(Principal
Financial and Accounting Officer)
|